![ATAGI recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years | Australian Government Department of Health and Aged Care ATAGI recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years | Australian Government Department of Health and Aged Care](https://www.health.gov.au/sites/default/files/images/news/2022/02/atagi-recommendations-for-use-of-pfizer-covid-19-vaccine-as-a-booster-dose-in-adolescents-aged-16-17-years.jpeg)
ATAGI recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years | Australian Government Department of Health and Aged Care
Delta Variant, Waning Immunity Reduced Pfizer Vaccine's Effectiveness Against Household Transmission < Yale School of Public Health
Ministry of Health - Guyana - Pfizer Vaccine for Adolescents - FAQ Can the Pfizer vaccine prevent transmission and infection? There is no data available that confirms that the Pfizer vaccine will
![Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7013e3_COVIDVaccineFieldEffectiveness_IMAGE_29Mar21_v2_1200x627.jpg?_=23735)
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December
![Yes, vaccines curb COVID-19 transmission — but that's not enough to protect those without a shot | CBC News Yes, vaccines curb COVID-19 transmission — but that's not enough to protect those without a shot | CBC News](https://i.cbc.ca/1.6104487.1626377105!/fileImage/httpImage/1233986271.jpg)
Yes, vaccines curb COVID-19 transmission — but that's not enough to protect those without a shot | CBC News
![Vaccin Pfizer et transmission de la COVID : un eurodéputé publie une vidéo trompeuse | Radio-Canada.ca Vaccin Pfizer et transmission de la COVID : un eurodéputé publie une vidéo trompeuse | Radio-Canada.ca](https://images.radio-canada.ca/q_auto,w_635/v1/ici-info/16x9/rob-roos-vaccin-pfizer-attention.jpg)
Vaccin Pfizer et transmission de la COVID : un eurodéputé publie une vidéo trompeuse | Radio-Canada.ca
UK Health Security Agency on Twitter: "People who became infected with #COVID19 three weeks after receiving one dose of the Pfizer-BioNTech or AstraZeneca #vaccine were 38-49% less likely to pass the virus
![Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows | Coronavirus | The Guardian Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows | Coronavirus | The Guardian](https://i.guim.co.uk/img/media/b5468ac59e6ba6db34ad5990f05ddd276d00dcf0/0_402_4549_2730/master/4549.jpg?width=1200&height=1200&quality=85&auto=format&fit=crop&s=ce04070f887b5509a3b419fb430e46fb)
Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows | Coronavirus | The Guardian
![Pfizer vaccine and isolation independently associated with reduced household transmission of SARS-CoV-2 Pfizer vaccine and isolation independently associated with reduced household transmission of SARS-CoV-2](https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2021/7/shutterstock_1690179541_(6)-2.jpg)
Pfizer vaccine and isolation independently associated with reduced household transmission of SARS-CoV-2
![Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study - The Lancet Infectious Diseases Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/54203763-0b7e-411e-b9f9-921c6e15c1fd/gr1_lrg.jpg)